This case involves a 56-year-old male patient who had dacryocystorhinostomy procedure to create a new tear drain between his eyes and nose. Pathology came back as benign. a little over a year later, the patient went for an evaluation of glaucoma. A second pathologist took a look at the previous surgical report and noted that the report indicated mucosa associated lymphoid tissue (MALT), which necessitated chemotherapy and radiation. An expert oncologist was sought to discuss the effects a 13-month delay might have on the treatment and prognosis of this patient.
Question(s) For Expert Witness
1. Do you routinely see patients with mucosa associated lymphoid tissue (MALT)?
2. Generally, what type of effect can a delay have on this type of patient?
Expert Witness Response E-034164
I spent the first 19 years of my career at Memorial Sloan Kettering Cancer Center in NYC where I directed the clinical research program in lymphoid leukemias. In 2009, I was recruited to be the inaugural Director of the Heme Malignancy and Bone Marrow Transplant program at Thomas Jefferson, a position I held until June, 2015. I have a great deal of expertise in low grade lymphoid malignancies such as MALT lymphomas. These are typically slow growing cancers but can "transform" into a more aggressive form which can be deadly. How much of an effect a 30-month delay would have on treatment and prognosis depends on the specifics of the case. It literally can range from no effect to life/death. I have reviewed several cases of failure to diagnose lymphoma in a timely manner but none of them have been of this specific sub-type.
About the author
Wendy Ketner, M.D.
Dr. Wendy Ketner is a distinguished medical professional with a comprehensive background in surgery and medical research. Currently serving as the Senior Vice President of Medical Affairs at the Expert Institute, she plays a pivotal role in overseeing the organization's most important client relationships. Dr. Ketner's extensive surgical training was completed at Mount Sinai Beth Israel, where she gained hands-on experience in various general surgery procedures, including hernia repairs, cholecystectomies, appendectomies, mastectomies for breast cancer, breast reconstruction, surgical oncology, vascular surgery, and colorectal surgery. She also provided care in the surgical intensive care unit.
Her research interests have focused on post-mastectomy reconstruction and the surgical treatment of gastric cancer, including co-authoring a textbook chapter on the subject. Additionally, she has contributed to research on the percutaneous delivery of stem cells following myocardial infarction.
Dr. Ketner's educational background includes a Bachelor's degree from Yale University in Latin American Studies and a Doctor of Medicine (M.D.) from SUNY Downstate College of Medicine. Moreover, she is a member of the Board of Advisors for Opollo Technologies, a fintech healthcare AI company, contributing her medical expertise to enhance healthcare technology solutions. Her role at Expert Institute involves leveraging her medical knowledge to provide insights into legal cases, underscoring her unique blend of medical and legal acumen.
